The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Biopharmaceutical Contract Manufacturing Market Research Report 2024

Global Biopharmaceutical Contract Manufacturing Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1806094

No of Pages : 89

Ask Your Query

Global Biopharmaceutical Contract Manufacturing market is projected to reach US$ 120590 million in 2029, increasing from US$ 87830 million in 2022, with the CAGR of 4.7% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Biopharmaceutical Contract Manufacturing market research.

Key companies engaged in the Biopharmaceutical Contract Manufacturing industry include Lonza Group, Baxter Biopharma Solutions, Samsung, Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim, Patheon, Rentschler Biotechnologie, Biomeva and Probiogen, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Biopharmaceutical Contract Manufacturing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biopharmaceutical Contract Manufacturing market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biopharmaceutical Contract Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Lonza Group
  •     Baxter Biopharma Solutions
  •     Samsung
  •     Fujifilm Diosynth Biotechnologies
  •     Boehringer Ingelheim
  •     Patheon
  •     Rentschler Biotechnologie
  •     Biomeva
  •     Probiogen
  •     Cytovance Biologics
  •     KBI Biopharma
  •     WuXi Biologics
  •     Abzena

Segment by Type

  •     Growth Factors
  •     Interferons
  •     Monoclonal Antibodies
  •     Recombinant Hormones
  •     Vaccines
  •     Insulin
  •     Others

Segment by Application

  •     Autoimmune Diseases
  •     Oncology
  •     Metabolic Diseases
  •     Ophthalmology
  •     Cardiovascular Diseases
  •     Infectious Diseases
  •     Neurology
  •     Respiratory Disorders
  •     Others

By Region

  •     North America (United States, Canada)
  •     Europe (Germany, France, U.K., Italy, Russia)
  •     Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  •     Latin America (Mexico, Brazil, Argentina)
  •     Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Biopharmaceutical Contract Manufacturing report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Growth Factors
        1.2.3 Interferons
        1.2.4 Monoclonal Antibodies
        1.2.5 Recombinant Hormones
        1.2.6 Vaccines
        1.2.7 Insulin
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Biopharmaceutical Contract Manufacturing Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Autoimmune Diseases
        1.3.3 Oncology
        1.3.4 Metabolic Diseases
        1.3.5 Ophthalmology
        1.3.6 Cardiovascular Diseases
        1.3.7 Infectious Diseases
        1.3.8 Neurology
        1.3.9 Respiratory Disorders
        1.3.10 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2018-2029)
    2.2 Biopharmaceutical Contract Manufacturing Growth Trends by Region
        2.2.1 Global Biopharmaceutical Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Size by Region (2018-2023)
        2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2024-2029)
    2.3 Biopharmaceutical Contract Manufacturing Market Dynamics
        2.3.1 Biopharmaceutical Contract Manufacturing Industry Trends
        2.3.2 Biopharmaceutical Contract Manufacturing Market Drivers
        2.3.3 Biopharmaceutical Contract Manufacturing Market Challenges
        2.3.4 Biopharmaceutical Contract Manufacturing Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue
        3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2018-2023)
        3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2018-2023)
    3.2 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
    3.4 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
        3.4.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2022
    3.5 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served
    3.6 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
    3.7 Date of Enter into Biopharmaceutical Contract Manufacturing Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Biopharmaceutical Contract Manufacturing Breakdown Data by Type
    4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2018-2023)
    4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2024-2029)

 5 Biopharmaceutical Contract Manufacturing Breakdown Data by Application
    5.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Application (2018-2023)
    5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2018-2029)
    6.2 North America Biopharmaceutical Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023)
    6.4 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2018-2029)
    7.2 Europe Biopharmaceutical Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023)
    7.4 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size (2018-2029)
    8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2018-2023)
    8.4 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America Biopharmaceutical Contract Manufacturing Market Size (2018-2029)
    9.2 Latin America Biopharmaceutical Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023)
    9.4 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size (2018-2029)
    10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2018-2023)
    10.4 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Lonza Group
        11.1.1 Lonza Group Company Detail
        11.1.2 Lonza Group Business Overview
        11.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
        11.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.1.5 Lonza Group Recent Development
    11.2 Baxter Biopharma Solutions
        11.2.1 Baxter Biopharma Solutions Company Detail
        11.2.2 Baxter Biopharma Solutions Business Overview
        11.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
        11.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.2.5 Baxter Biopharma Solutions Recent Development
    11.3 Samsung
        11.3.1 Samsung Company Detail
        11.3.2 Samsung Business Overview
        11.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
        11.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.3.5 Samsung Recent Development
    11.4 Fujifilm Diosynth Biotechnologies
        11.4.1 Fujifilm Diosynth Biotechnologies Company Detail
        11.4.2 Fujifilm Diosynth Biotechnologies Business Overview
        11.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
        11.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.4.5 Fujifilm Diosynth Biotechnologies Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Detail
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
        11.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 Patheon
        11.6.1 Patheon Company Detail
        11.6.2 Patheon Business Overview
        11.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
        11.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.6.5 Patheon Recent Development
    11.7 Rentschler Biotechnologie
        11.7.1 Rentschler Biotechnologie Company Detail
        11.7.2 Rentschler Biotechnologie Business Overview
        11.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
        11.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.7.5 Rentschler Biotechnologie Recent Development
    11.8 Biomeva
        11.8.1 Biomeva Company Detail
        11.8.2 Biomeva Business Overview
        11.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
        11.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.8.5 Biomeva Recent Development
    11.9 Probiogen
        11.9.1 Probiogen Company Detail
        11.9.2 Probiogen Business Overview
        11.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
        11.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.9.5 Probiogen Recent Development
    11.10 Cytovance Biologics
        11.10.1 Cytovance Biologics Company Detail
        11.10.2 Cytovance Biologics Business Overview
        11.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
        11.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.10.5 Cytovance Biologics Recent Development
    11.11 KBI Biopharma
        11.11.1 KBI Biopharma Company Detail
        11.11.2 KBI Biopharma Business Overview
        11.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
        11.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.11.5 KBI Biopharma Recent Development
    11.12 WuXi Biologics
        11.12.1 WuXi Biologics Company Detail
        11.12.2 WuXi Biologics Business Overview
        11.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
        11.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.12.5 WuXi Biologics Recent Development
    11.13 Abzena
        11.13.1 Abzena Company Detail
        11.13.2 Abzena Business Overview
        11.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
        11.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2018-2023)
        11.13.5 Abzena Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock